Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good info. Careful. If they want them this bad there is a reason. Someone may be trying to buy this out on the cheap.
We got a winner. ....... or it’s something really close to this. It’s all in the patents and as some have stated on here, The market is giving them zero value.
If I was a betting man..... the same group who’s “CEO” commutes 600 miles to work everyday.
Sumo!!!!
Best of luck Quid! Hope it works out for all of us!
Until it’s bought out for 5 billion and everyone wishes they would’ve bought more
I know a lot of Titan investors. I would venture to guess the total of them would be over 6-700,000 shares and not one of them sold. Matter of fact, most added to their position as this dropped. Point being I highly doubt this. This is all manipulation. In a week or much sooner Titan will have anywhere between 50-75 million cash on hand, several more million in prototypes, patents(really really good patents), a whos who Surgical advisory team, top notch manufacturing and distribution channel, best in class customized simulation software training partner, and a clear path to FDA and CE approvals with zero debt and will be sitting with a 70-90 million market Cap. The cash on hand alone is almost worth more than the market cap. Shorters try to scare all you want. Those are the facts. Titan longs are not dummies. Better cover that short position soon.
I agree. However, it will be more than 1/3 of the shares ownership
Meanwhile, JNJs accumulating a huge digital team in Providence RI.
Exactly. Well said
Thanks for coming over LTG for those of us not following and would like some DD on the competition when is it expected that Surgibot will hit the market. Does TRXC have any prebuys lined up?
Same guys in on the Medtronic covidien deal ?
Or would he...... trust the process
Hold!!!!
HOLD!!!!!
That my friend is a bunch of baloney. You really think they were better grabbing 8 million here and there with nobodies on the OTC was the answer? They had to do this. A reverse split was an excellent decision in this case. Very soon they will be fully funded with the wind at their back and you, as well as others, will have loaded up your share count with scare tactics and rehashing the past that has nothing to do with today.
Hold.........HOLD!!........HOLD!!!!!!.........HOLD!!!!!!!!!!!
NOWWWW!!!!!!!!!!
Just waiting for the now part!
Great point Invest. There’s another big company who took a particular interest as well in scarless surgery.
They have trialed it at IRCAD Brazil as well.
This is what we are hearing out of Columbia. Should be pretty significant. Not to mentioned we heard feedback from them during Society of Robotic Surgery Meeting. Tons about it on Twitter
https://titanmedicalinc.com/investors/pre-clinical-publications/
6. Reverse Objective Structured Assessment of Technical Skills (Reverse-OSATS) as a means of measuring the capability of the Titan Medical SPORT Surgical System on core surgical principles by Chetna Arora, MD, Arnold P. Advincula, MD (both from Columbia University Medical Center) and William B. Burke, MD (Stony Brook Cancer Center)
Submitted at Society of European Robotic Gynecologic Surgeons Meeting, Milan, Italy, September 2018
7. Reverse Objective Structured Assessment of Technical Skills (Reverse-OSATS) as a means of measuring the capability of the Titan Medical SPORT Surgical System on core surgical principles by Chetna Arora, MD, Arnold P. Advincula, MD (both from Columbia University Medical Center) and William B. Burke, MD (Stony Brook Cancer Center)
Submitted at American Association of Gynecologic Laparoscopist Meeting, Las Vegas, NV, November 2018
I agree with you on all your points. And I was only making a point. The point being..... that’s alot of leverage. I understand the Medtronic and JNJs of the world have even more leverage. However, Robotics is and will be kind of a big deal in hospitals. Do you think intuitive will not be able to drastically reduce their costs both capital and per procedure when the time calls for it? Do you believe they haven’t been working on ways to reduce costs when planning for the day when JNJ/MEdtronic/Verb have an offering?
All will be fine but the big strategics don’t get into a market to be #2 or #3 and if they want to be #1 they will want to have a full offering. That’s all I’m saying. Now that might mean one of them buys Intuitive but not a chance they are coming to market with one robot that fits in a closet down the hall well. And yes I do believe Sport will be in their portfolio to be “best in class”
That’s what I think they’ll probably do.
Question of the day - how will the big strategics(Ethicon/Medtronic/Verb) answer Hospitals when they are told Intuitive(who we’ve been working with for years now) is now telling me they can supply me with a multiport, single port and lung robot at a fraction of the cost if I add all 3 along with reduced service and discounts on tools and consumables? Do you think the answer will be “well we’ve got a really cool multiport robot that has some software upgrades” and it’s J and J, Medtronic and Google? How do you think that will go over? If you assume, not well, what is their strategy? How do they compete with Intuitive? This should help
You mean the same guys who loaded up everytime this diluted or dropped for no good reason? I think those guys did just that.
Just a suggestion for a struggling investor. Get out from behind the numbers because very soon all the worrying about those numbers is gonna be useless. There are better answers than the financing. Go do some real due diligence. The answers have always been there. They’ve done their absolute best to keep it under wraps.
It’s all in the patents(have to dig deeper than just Titan Medical). The contract manufacturer and distributor who is putting significant resources on both sides of the United States and on the other side of world(432,000 sq ft) for a tiny “underfunded” Surgical Robotics company. The trials being done across many specialties on 3 continents(North America/South America/Europe). A who’s who of surgical robotics doctors lining up to trial it. Amadeus technology still in play for another company? The importance of understanding Single Port tech and what it’s prevalence will be in the future and who are the potential players there. Also the companies most likely to have an interest in a Single Port platform because of their past history(areas of past research). The shareholders rights plan going from really important to not important at all after your boy Hargrove(who I think is pretty sharp, btw) resign and Titan just allowing it to expire with no real good reason as to why.
That should be a pretty good start for you.
Possibly. I do find it interesting that we haven’t heard a thing about renewal of this plan. It was a pretty big deal when it was implemented. I would think it would be just as important, if not more now.
Wrong. It’s multi platforms. Gotta do some DD instead of hanging out here all day and night.
Meanwhile Intuitive is still not selling their single port
It certainly looks like machine learning to me.
I might be delusional but at least I knew the timelines without having to listen to that call.
It will most likely be 2020 so that they have some studies for hospital committees. Mother company will want them before coming to market.
Interesting point. The only way it could be strategic for a crosslift is if it’s a big player who would move the needle and is willing to share their interest. The others thing is, I’m sure their are some capital requirements to fulfill in order to uplift/crosslift. Could this be why they are grabbing money now(before RS approval expires)?
I’ll say this all the big companies haven’t been able to produce a viable robot to date with all kinds of resources. Most have pushed their Timelines back including J and J and Medtronic. This is not common widget made and used in every OR. There are incredible complexities that need to be ironed out. I’m not giving them a pass but feel very confident because of the “teams” that are developing this.
Certainly can
It’s all in the patents
Would love to get an answer on this? Maybe the acquirer is already a voting majority otherwise, why wouldn’t they extend it?
Yes he does. 2 guys with completely different backgrounds and experiences and the exact same MO. I wonder why?
Who?
Longtai being one of several. I am sure there are others. Who is buying up these offers and who is exercising the warrants to the tune of millions of dollars at this point in the game?
Must have gotten enough shares through these shell companies for majority ownership since there has been no talk of renewing the shareholders rights plan. Don’t need that anymore to protect against unsolicited bids. I don’t think we are ever uplisting btw. They are very happy with the secrecy the OTC provides.
Ok who were the large shareholders who voted them out?
What I don’t understand is when will everyone realize that J and J is pulling all the strings with their shell companies? You really don’t find it ridiculous that they refuse to name partners despite the fact that they are this tiny, financially desperate, trading on the OTC company. What partner(let alone all of them) would care not to be named? How many Roth and other financial conferences are they going to go to and come away empty handed. All for show imo. My biggest question will be with this kind of control what does this mean for all of us investors when they decide to acquire/partner/IPO etc. Will we realize the types of returns we should be expecting or will this sell on the cheap to the company that’s been pulling the strings the entire time?